作者: Geert A. Simkens , Thijs R. van Oudheusden , Misha D. Luyer , Simon W. Nienhuijs , Grard A. Nieuwenhuijzen
DOI: 10.1245/S10434-014-4297-Y
关键词: Early Recurrence 、 Hyperthermic intraperitoneal chemotherapy 、 Survival rate 、 Postoperative complication 、 Surgical oncology 、 Young adult 、 Surgery 、 Combined Modality Therapy 、 General surgery 、 Medicine 、 Colorectal cancer
摘要: Background The prognosis of patients with peritoneally metastasized colorectal cancer has improved significantly the introduction cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). Although a macroscopically complete resection is achieved in nearly every patient, recurrence rates are high. This study aims to identify risk factors for early recurrence, thereby offering ways reduce its occurrence.